CXADR

CXADR

CXADR 분자 정보

Molecule Name
Calcium sensing receptor
분자 별명
CXADR,CAR,CAR4,6,HCAR
Drug Development Progress
임상 약물 수5
시판 약물 수6
최고 연구 개발 단계Approved
표적 별명
Parathyroid cell calcium-sensing receptor 1,FHH,FIH,HHC,Receptors, Calcium-Sensing,Extracellular calcium-sensing receptor,hCasR,GPRC2A,Calcium Sensing Receptor,Parathyroid Ca(2+)-Sensing Receptor 1,Severe Neonatal Hyperparathyroidism,Calcium-Sensing Receptor,HYPOC1,NSHPT,PCaR1,EIG8,HHC1,CaSR,CAR,Hypocalciuric Hypercalcemia 1
분자 배경
Coxsackie virus and adenovirus receptor (CXADR) is also known as CAR, is a type I transmembrane glycoprotein for group B coxsackie viruses and subgroup C adenoviruses, and belongs to the CTX family of the Ig superfamily. CAR is strongly expressed in the developing central nervous system. It functions as a homophilic and also as a heterophilic cell adhesion molecule through its interactions with extracellular matrix glycoproteins such as: fibronectin, agrin, laminin-1 and tenascin-R. Human CXADR protein contains a signal sequence, a extracellular domain (ECD) with a V­ type (D1) and a C2­ type (D2) Ig­like domain, a  transmembrane segment and a intracellular domain. D1 is thought to be responsible for homodimer formation in trans within tight junctions, and is necessary and sufficient for adenovirus binding. Variants of CXADR are attached to the cell membrane by a GPI- anchor.

CXADR 제품 목록

No Data
You Have Viewed 0 Of 0 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

임상 약물 정보

영어 이름연구 코드연구 개발 단계회사적응증임상 시험
Encaleret sulfateMK-5442; JTT-305; BBP-305; CLTX-305Phase 3 ClinicalJapan Tobacco (Hong Kong) Ltd
Osteoporosis; Hypocalcemia; Osteoporosis, Postmenopausal; Hypoparathyroidism
상세
SHR-6508SHR-6508Phase 3 ClinicalShanghai Hengrui Pharmaceutical Co Ltd
Hyperparathyroidism, Secondary; Kidney Diseases; Renal Insufficiency, Chronic; Hyperparathyroidism
상세
LNP-1892LNP-1892Phase 2 ClinicalLupin Ltd
Hyperparathyroidism
상세
DS-9194bDS-9194bPhase 1 ClinicalDaiichi Sankyo Co Ltd
Osteoporosis
상세
RT-102(Rani)RT-102Phase 1 ClinicalRani Therapeutics Holdings Inc
Osteoporosis
상세

시판 약물 정보

영어 이름연구 코드연구 개발 단계회사가장 빠른 브랜드 이름가장 빠른 승인 국가가장 빠른 적응증가장 빠른 승인 회사가장 빠른 승인 날짜적응증임상 시험
UpacicalcetSK-1403; AJT-240ApprovedAjinomoto Co Incウパシタ, UpasitaJapanHyperparathyroidism, SecondarySanwa Kagaku Kenkyusho Co Ltd2021-06-23
Hyperparathyroidism, Secondary
상세
Parathyroid hormone (Shire)SHP-634; ALX-111; 423562; NPSP-795; rhPTH (1-84); SHP-635; rhPTH-1-84; PTH (1-84); SB-423562; PTH 1-84; NPSP-558ApprovedShireNatpara, Preotact, NatparUnited StatesHypoparathyroidismNps Pharmaceuticals, Inc2006-04-24
Osteoporosis; Bone Diseases, Endocrine; Osteoporosis, Postmenopausal; Hypocalcemia; Hypoparathyroidism; Hyperparathyroidism; Plaque psoriasis
상세
Cinacalcet HydrochlorideAMG-073.HCl; NPS-1493; AMG-073; KRN-1493ApprovedAmgen IncParareg, Sensipar, Mimpara, Regpara, 盖平, Sensipar/MimparaUnited StatesHypercalcemia; Hyperparathyroidism, SecondaryAmgen Inc2004-03-08
Hyperparathyroidism, Secondary; Rejection of renal transplantation; Hypophosphatemia; Edema, Cardiac; Nephrosis; Renal Insufficiency; Parathyroid Neoplasms; Hypercalcemia; Kidney Diseases; Hyperparathyroidism, Primary; Prostatic Neoplasms; Osteomalacia; Renal Insufficiency, Chronic; Kidney Failure, Chronic; Hyperparathyroidism; Chronic Kidney Disease-Mineral and Bone Disorder
상세
Etelcalcetide HydrochlorideONO-5163; KAI-4169; AMG-416; KAI-4169-HClApprovedAmgen IncParsabivEUHyperparathyroidism, SecondaryAmgen Europe Bv2016-11-11
Hyperparathyroidism, Secondary; Edema, Cardiac; Renal Insufficiency, Chronic; Kidney Failure, Chronic
상세
Strontium RanelateS-12911; S-12911-2; FK-481ApprovedLaboratoires ServierOsseor, Protos, Protelos, 欧思美Mainland ChinaOsteoporosis, PostmenopausalLes Laboratoires Servier2004-09-20
Osteoporosis, Postmenopausal
상세
EvocalcetKHK-7580; MT-4580ApprovedMitsubishi Tanabe Pharma CorpOrkediaJapanHyperparathyroidism, SecondaryKyowa Hakko Kirin Co Ltd2018-03-23
Hyperparathyroidism, Secondary; Parathyroid Neoplasms; Hyperparathyroidism, Primary; Hyperparathyroidism
상세